These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 26373345)

  • 1. Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications.
    Gaj T; Epstein BE; Schaffer DV
    Mol Ther; 2016 Mar; 24(3):458-64. PubMed ID: 26373345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic and Clinical Application of Adeno-Associated Virus-Mediated Genome Editing.
    He X; Xie H; Liu X; Gu F
    Hum Gene Ther; 2019 Jun; 30(6):673-681. PubMed ID: 30588843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome engineering using Adeno-Associated Virus (AAV).
    Howes R; Schofield C
    Methods Mol Biol; 2015; 1239():75-103. PubMed ID: 25408402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multifunctional AAV-CRISPR-Cas9 and its host response.
    Chew WL; Tabebordbar M; Cheng JK; Mali P; Wu EY; Ng AH; Zhu K; Wagers AJ; Church GM
    Nat Methods; 2016 Oct; 13(10):868-74. PubMed ID: 27595405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-Associated Virus-Mediated Delivery of CRISPR-Cas Systems for Genome Engineering in Mammalian Cells.
    Gaj T; Schaffer DV
    Cold Spring Harb Protoc; 2016 Nov; 2016(11):. PubMed ID: 27803249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV Vectorization of DSB-mediated Gene Editing Technologies.
    Moser RJ; Hirsch ML
    Curr Gene Ther; 2016; 16(3):207-19. PubMed ID: 27280971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor targeting of adeno-associated virus vectors.
    Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
    Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered Viruses as Genome Editing Devices.
    Chen X; Gonçalves MA
    Mol Ther; 2016 Mar; 24(3):447-57. PubMed ID: 26336974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery.
    Gaj T; Staahl BT; Rodrigues GMC; Limsirichai P; Ekman FK; Doudna JA; Schaffer DV
    Nucleic Acids Res; 2017 Jun; 45(11):e98. PubMed ID: 28334779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells.
    Asuri P; Bartel MA; Vazin T; Jang JH; Wong TB; Schaffer DV
    Mol Ther; 2012 Feb; 20(2):329-38. PubMed ID: 22108859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
    Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
    Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
    Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
    Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of AAV vector integration into CRISPR-induced DNA breaks.
    Hanlon KS; Kleinstiver BP; Garcia SP; Zaborowski MP; Volak A; Spirig SE; Muller A; Sousa AA; Tsai SQ; Bengtsson NE; Lööv C; Ingelsson M; Chamberlain JS; Corey DP; Aryee MJ; Joung JK; Breakefield XO; Maguire CA; György B
    Nat Commun; 2019 Sep; 10(1):4439. PubMed ID: 31570731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting.
    Rahman SH; Bobis-Wozowicz S; Chatterjee D; Gellhaus K; Pars K; Heilbronn R; Jacobs R; Cathomen T
    Hum Gene Ther; 2013 Jan; 24(1):67-77. PubMed ID: 23072634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of adeno-associated virus (AAV) and recombinant AAV vectors.
    McCarty DM; Young SM; Samulski RJ
    Annu Rev Genet; 2004; 38():819-45. PubMed ID: 15568995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.
    Dong JY; Fan PD; Frizzell RA
    Hum Gene Ther; 1996 Nov; 7(17):2101-12. PubMed ID: 8934224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverted terminal repeats of adeno-associated virus decrease random integration of a gene targeting fragment in Saccharomyces cerevisiae.
    Galli A; Cervelli T
    BMC Mol Biol; 2014 Feb; 15():5. PubMed ID: 24521444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted genome editing by recombinant adeno-associated virus (rAAV) vectors for generating genetically modified pigs.
    Luo Y; Kofod-Olsen E; Christensen R; Sørensen CB; Bolund L
    J Genet Genomics; 2012 Jun; 39(6):269-74. PubMed ID: 22749014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV-Mediated Gene Delivery to the Liver: Overview of Current Technologies and Methods.
    Palaschak B; Herzog RW; Markusic DM
    Methods Mol Biol; 2019; 1950():333-360. PubMed ID: 30783984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.